Literature DB >> 8306503

High serum levels of soluble CD8 in insulin-dependent diabetes.

E Di Cesare1, M Previti, M C Ingemi, G F Bagnato, D Cucinotta.   

Abstract

In type 1 (insulin-dependent) diabetes mellitus (IDDM) CD8+ T cells represent the majority of lymphocytes which infiltrate the pancreatic islets during beta cell destruction. Soluble CD8 antigen (sCD8) has been shown to correlate with CD8 cell subset activation. In this study we measured by ELISA sCD8 levels in sera from: 33 newly diagnosed IDDM patients; 29 type 1 diabetics with duration of disease more than 1 year; 37 healthy siblings of IDDM patients; 19 healthy controls. Sera from both groups of IDDM patients and from healthy siblings exhibited soluble CD8 mean levels significantly higher than controls (P = 0.0001, P < 0.003, P < 0.03 respectively). Soluble CD8 levels above the normal range (mean +/- 2 s.d. of controls) were found in a percentage of newly diagnosed subjects (54.5%) significantly higher than in subjects with a long-standing duration of disease (6.9%, P < 0.0005) and healthy siblings (16.2%, P < 0.002). Our results suggest that the raised levels of soluble CD8 near to diabetes onset may indicate the activation of CD8+ T cells probably responsible for the autoimmune beta cell destruction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306503      PMCID: PMC1534936          DOI: 10.1111/j.1365-2249.1994.tb06524.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Prevalence of antibodies to nucleic acids in insulin-dependent diabetics and their relatives.

Authors:  S W Huang; L H Haedt; S Rich; J Barbosa
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

2.  Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies.

Authors:  E Bonifacio; A Lernmark; R L Dawkins
Journal:  J Immunol Methods       Date:  1988-01-21       Impact factor: 2.303

3.  Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression.

Authors:  L A O'Reilly; P R Hutchings; P R Crocker; E Simpson; T Lund; D Kioussis; F Takei; J Baird; A Cooke
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

4.  Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse.

Authors:  T W Kay; I L Campbell; L C Harrison
Journal:  J Autoimmun       Date:  1991-04       Impact factor: 7.094

5.  Cytokines in sera from insulin-dependent diabetic patients at diagnosis.

Authors:  M G Cavallo; P Pozzilli; C Bird; M Wadhwa; A Meager; N Visalli; A J Gearing; D Andreani; R Thorpe
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

6.  Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.

Authors:  S Baekkeskov; M Landin; J K Kristensen; S Srikanta; G J Bruining; T Mandrup-Poulsen; C de Beaufort; J S Soeldner; G Eisenbarth; F Lindgren
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

7.  Immune activation in measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

8.  Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.

Authors:  C Agostini; G Semenzato; F Vinante; A Sinicco; L Trentin; R Zambello; B Zuppini; R Zanotti; F Siviero; D Veneri
Journal:  Clin Immunol Immunopathol       Date:  1989-01

9.  Thyroglobulin and microsomal antibodies in patients with insulin dependent diabetes mellitus and their relatives.

Authors:  K Nagaoka; T Sakurami; N Nabeya; H Imura; S Kuno
Journal:  Endocrinol Jpn       Date:  1979-04

10.  Spontaneous release of the Leu-2 (T8) molecule from human T cells.

Authors:  J Fujimoto; S Levy; R Levy
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  2 in total

1.  Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).

Authors:  M Itoh; K Uchimura; N Hayakawa; M Makino; R Hayashi; M Nagata; H Kakizawa; A Nagasaka; H Sakamoto; H Kuzuya
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

2.  Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.

Authors:  P Di Bonito; A De Bellis; B Capaldo; S Turco; G Corigliano; E Pace; A Bizzarro
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.